WO2004002507A8 - Herbal composition for treating or alleviating vascular headaches, neurological conditions and neurodegenerative diseases - Google Patents

Herbal composition for treating or alleviating vascular headaches, neurological conditions and neurodegenerative diseases

Info

Publication number
WO2004002507A8
WO2004002507A8 PCT/US2003/012593 US0312593W WO2004002507A8 WO 2004002507 A8 WO2004002507 A8 WO 2004002507A8 US 0312593 W US0312593 W US 0312593W WO 2004002507 A8 WO2004002507 A8 WO 2004002507A8
Authority
WO
WIPO (PCT)
Prior art keywords
treating
neurodegenerative diseases
herbal composition
neurological conditions
vascular headaches
Prior art date
Application number
PCT/US2003/012593
Other languages
French (fr)
Other versions
WO2004002507A1 (en
Inventor
Chandrasekhara Rao Kuppapm
Original Assignee
Chada Murali Krishna
Chandrasekhara Rao Kuppapm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chada Murali Krishna, Chandrasekhara Rao Kuppapm filed Critical Chada Murali Krishna
Priority to JP2004517516A priority Critical patent/JP2006508902A/en
Priority to AU2003231061A priority patent/AU2003231061A1/en
Priority to DE60325214T priority patent/DE60325214D1/en
Priority to EP03724185A priority patent/EP1519738B8/en
Publication of WO2004002507A1 publication Critical patent/WO2004002507A1/en
Publication of WO2004002507A8 publication Critical patent/WO2004002507A8/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/67Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

The invention relates to an herbal composition comprising extract of plant Moringa Oleifera, plant Piper Nigrum and plant Nicotiana Tabacum for treating or alleviating vascular headaches, neurological conditions and neurodegenerative diseases.
PCT/US2003/012593 2002-06-26 2003-04-24 Herbal composition for treating or alleviating vascular headaches, neurological conditions and neurodegenerative diseases WO2004002507A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2004517516A JP2006508902A (en) 2002-06-26 2003-04-24 Botanical composition for treating or alleviating vascular headaches, neurological diseases, and neurodegenerative diseases
AU2003231061A AU2003231061A1 (en) 2002-06-26 2003-04-24 Herbal composition for treating or alleviating vascular headaches, neurological conditions and neurodegenerative diseases
DE60325214T DE60325214D1 (en) 2002-06-26 2003-04-24 HERBAL COMPOSITION FOR THE TREATMENT OR REDUCTION OF MIGRAINE HEADACHES, NEUROLOGICAL STATES AND NEURODEEGENERATIVE DISEASES
EP03724185A EP1519738B8 (en) 2002-06-26 2003-04-24 Herbal composition for treating or alleviating vascular headaches, neurological conditions and neurodegenerative diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/180,264 US7070817B2 (en) 2002-06-26 2002-06-26 Herbal composition for treating or alleviating vascular headaches, neurological conditions and neurodegenerative diseases
US10/180,264 2002-06-26

Publications (2)

Publication Number Publication Date
WO2004002507A1 WO2004002507A1 (en) 2004-01-08
WO2004002507A8 true WO2004002507A8 (en) 2006-02-02

Family

ID=29778898

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/012593 WO2004002507A1 (en) 2002-06-26 2003-04-24 Herbal composition for treating or alleviating vascular headaches, neurological conditions and neurodegenerative diseases

Country Status (8)

Country Link
US (1) US7070817B2 (en)
EP (1) EP1519738B8 (en)
JP (1) JP2006508902A (en)
AT (1) ATE416777T1 (en)
AU (1) AU2003231061A1 (en)
DE (1) DE60325214D1 (en)
ES (1) ES2319402T3 (en)
WO (1) WO2004002507A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070218002A1 (en) * 2004-05-07 2007-09-20 Barrio Jorge R Method for Detecting Alzheimer's Disease and other Forms of Dementia, and Measuring Their Progression
WO2006070386A1 (en) * 2004-12-27 2006-07-06 Council Of Scientific And Industrial Research Herbal formulation for the treatment of piles
US20060222682A1 (en) * 2005-03-18 2006-10-05 Andrews David A Nutraceutical Moringa composition
US20080139510A1 (en) * 2006-12-07 2008-06-12 Abe Rose Treatment of migraine headaches with sublingual amino acids
US7747551B2 (en) * 2007-02-21 2010-06-29 Neurovista Corporation Reduction of classification error rates and monitoring system using an artificial class
EP2011495A1 (en) * 2007-07-03 2009-01-07 Sygnis Bioscience GmbH & Co. KG Use of piperine and derivatives thereof for the therapy of neurological conditions
WO2009066303A2 (en) * 2007-11-22 2009-05-28 Ganga Raju Gokaraju New synergistic phytochemical composition for the treatment of obesity
US20130108723A1 (en) * 2011-10-31 2013-05-02 William John Martin Use of Plants and Plant Extracts to Activate Water, Alcohol and Other Liquids
CA2928752A1 (en) * 2013-11-01 2015-05-07 Rutgers, The State University Of New Jersey Extracts from plants of the moringaceae family and methods of making
TWI581793B (en) * 2016-02-27 2017-05-11 盧銘章 Sodium methylarsonate is newly applied in the field of medical science as an inhibitor for glycoprotein in pathogens
KR101689652B1 (en) 2016-08-31 2016-12-26 농업회사법인 천애지 주식회사 Drink composition having improved storage stability and the method thereof
GB2598160A (en) * 2020-08-21 2022-02-23 Manent Tomas Lluis Phytotherapeutic composition
US20240050504A1 (en) * 2022-08-11 2024-02-15 Hong Kong Chinese Medicine Ophthalmology Institute Limited Traditional chinese medicine eye drops and the preparation method thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857325A (en) * 1985-04-24 1989-08-15 Bar-Ilan University Antioxidant compositions and methods
IL80783A0 (en) * 1986-10-17 1987-02-27 Univ Bar Ilan Food supplements
US4986985A (en) * 1987-11-02 1991-01-22 Bar Ilan University Method of treating skin virus infections
US5276043A (en) 1992-04-10 1994-01-04 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5536506A (en) 1995-02-24 1996-07-16 Sabinsa Corporation Use of piperine to increase the bioavailability of nutritional compounds
US5693327A (en) 1995-07-12 1997-12-02 Shah; Eladevi Herbal compositions
US6383495B1 (en) 1997-12-08 2002-05-07 Council Of Scientific & Industrial Research Herbal formulation useful for treatment of skin disorders
FR2776519B1 (en) 1998-03-24 2000-11-17 Serobiologiques Lab Sa USE OF AT LEAST ONE PROTEIN EXTRACT FROM SEEDS OF PLANTS OF THE MORINGA GENUS AND CORRESPONDING COSMETIC AND / OR PHARMACEUTICAL COMPOSITION
US6350479B1 (en) 1998-06-05 2002-02-26 Regent Court Technologies Treating depression with alcohol extracts of tobacco
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
DE19858741A1 (en) * 1998-12-18 2000-06-21 Schwabe Willmar Gmbh & Co Use of kava extract as medicament for treating extrapyramidal motor disorders such as neuroleptic-induced dyskinesia and Parkinson's disease
US6365601B1 (en) * 1999-09-16 2002-04-02 Council Of Scientific And Industrial Research Process for extraction of piperine from piper species
US6573299B1 (en) * 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
IL151334A0 (en) * 2000-02-28 2003-04-10 Natural Remedies Private Ltd An improved herbal composition having antiallergic properties and a process for the preparation thereof
US6517861B2 (en) * 2001-01-22 2003-02-11 Council Of Scientific And Industrial Research Composition of herbal biscuits for lactating mothers acting as dietary supplement and process for preparation thereof
GB0116948D0 (en) 2001-07-11 2001-09-05 Sahajanand Biotech Private Ltd Herbal formulation
US6667047B2 (en) 2001-07-27 2003-12-23 International Flute Technologies Ltd Ultra-stable composition comprising moringa oil and its derivatives and uses thereof
US6855347B2 (en) * 2002-03-25 2005-02-15 Council Of Scientific And Industrial Research Composition for treating gastric ulcer and a process for preparing the same
US6582733B1 (en) 2002-05-15 2003-06-24 Som C. Pruthi Composition for the treatment of hepatitis including HCV

Also Published As

Publication number Publication date
US7070817B2 (en) 2006-07-04
EP1519738B1 (en) 2008-12-10
JP2006508902A (en) 2006-03-16
AU2003231061A1 (en) 2004-01-19
US20040001896A1 (en) 2004-01-01
ES2319402T3 (en) 2009-05-07
DE60325214D1 (en) 2009-01-22
AU2003231061A8 (en) 2004-01-19
EP1519738B8 (en) 2009-04-22
ATE416777T1 (en) 2008-12-15
EP1519738A1 (en) 2005-04-06
WO2004002507A1 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
WO2004002507A8 (en) Herbal composition for treating or alleviating vascular headaches, neurological conditions and neurodegenerative diseases
WO2002047706A3 (en) Selective cox-2 inhibition from plant extracts
WO2008011363A3 (en) Quercetin-containing compositions
WO2002017914A8 (en) Fused pyrrolocarbazoles against inflammation
WO2009001362A3 (en) Herbal compositions for the treatment of diabetes and/or conditions associated therewith
WO2006071960A3 (en) Compositions and methods of treating cell proliferation disorders
WO2000010507A3 (en) Use of melanin for inhibition of angiogenesis and macular degeneration
WO2002096361A3 (en) 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
WO2002009815A3 (en) New pharmaceutical composition
TW200612841A (en) Method of preparing tea extract and tea flavor
PL350300A1 (en) Composition for treating obesity and aesthetic treatment method
TW200616656A (en) Angelicae sinensis extracts useful for treatment of cancers
YU12404A (en) Artichoke leaf extracts
WO2004011012A3 (en) Stem cells for treating pancreatic damage
GEP20115332B (en) Herbal composition for inflammatory disorders
WO2006060582A3 (en) Nematicides from juglandaceae and methods of use thereof
WO2005099721A3 (en) Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof
WO2010013254A3 (en) Withania somnifera plant extract and method of preparation thereof
WO2004039328A3 (en) Fludrocortisone treatment for hearing loss
WO2007044751A3 (en) Polynucleotides encoding phenylpropanoid pathway enzymes in coffee
WO2006025068A8 (en) A purified arabinogalactan-protein (agp) composition
WO2005063764A3 (en) Fused pyrrolocarbazoles and methods for the preparation thereof
HK1048580A1 (en) Method for treatment of chronic venous insufficiencies using an extract of red vine leaves.
WO2004021988A3 (en) Treatment of pain by inhibition of p38 map kinase
WO2010134769A3 (en) Composition for preventing or treating irritable bowel syndrome

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BR CA CN ID IL IN JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003724185

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2852/CHENP/2004

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2004517516

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2003724185

Country of ref document: EP

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 02/2004 UNDER (71, 72) DELETE "CHADA, MURALI, KRISHNA"; UNDER (71) ADD "CHADA, MURALI, KRISHNA"